詳細
Liquid Biopsies such as circulating tumour DNA (ctDNA) have emerged as a noninvasive biomarker to track tumour burden and allow real-time monitoring of the cancer genome in blood. Through recent advances in genomic technologies including next-generation sequencing, ctDNA analysis can be used across a range of malignancies to detect minimal residue disease, guide treatment selection and detect the emergence of treatment resistance. This webinar will outline the technological advances in ctDNA analysis, highlight the role of ctDNA analysis in the clinical management of cancer patients and the future potential for ctDNA analysis to impact cancer care.
The key things you will learn in this webinar are:
- Understand the technological advances in ctDNA (circulating tumour) analysis
- Highlight the role of ctDNA analysis in management of cancer patients
- Understand the future potential of ctDNA analysis in cancer care
Speaker:
 |
Dr Stephen Wong |
Fill Out Form to Access Webinar
ご提供いただいた個人情報は、お客様へのサポート、サービス、および販売活動の目的にのみ使用させていただきます。
- 日時
- 2025/03/12
- 05:00 PM
- Location
- Japan
- Asia
- Presenter
- Dr Stephen Wong
Head of the Cancer Genomics Translational Research Centre, Peter MacCallum Cancer Centre - Topic
- Oncology